Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Sabri

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Surgical Neurology|July 2, 1999
Preoperative PET activation for assessment of motor cortex area in precentral chondromaM Schreckenberger, U Spetzger, O Sabri, et al.
Scientific Reports|May 11, 2026
Efficiency of afamin and fibroblast growth factor 21 for early prediction of gestational diabetes mellitusAbdelrahman O Sabri, Mostafa M Elhady, Eman H A Hemida, et al.
Stroke|March 6, 1999
Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathyO Sabri, E B Ringelstein, D Hellwig, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1997
Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PETU Cremerius, R Bares, J Weis, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 1995
[Comparison of relative 18FDG uptake with metabolic rate (MRGlucose) in the myocardium in CAD, classified by 99m-Tc-MIBI]U Büll, Y Foroutan, D Hellwig, et al.
EJNMMI Research|June 4, 2016
Impact of attenuation correction on clinical [(18)F]FDG brain PET in combined PET/MRIP Werner, M Rullmann, A Bresch, et al.
Nuklearmedizin. Nuclear Medicine|December 6, 2008
[FDG-PET in Hodgkin lymphoma]C Kobe, M Dietlein, C Mauz-Körholz, et al.
European Journal of Neurology|April 29, 2006
Correlation of cognitive status, MRI- and SPECT-imaging in CADASIL patientsR Scheid, C Preul, T Lincke, et al.
Journal of Neurology|April 12, 2006
Profound midbrain atrophy in patients with Wilson's disease and neurological symptoms?K Strecker, J P Schneider, H Barthel, et al.
Nuclear Medicine Communications|December 1, 1996
Imaging of beta-oxidation by static PET with 14(R,S)-[18F]-fluoro-6-thiaheptadecanoic acid (FTHA) in patients with advanced coronary heart disease: a comparison with 18FDG-PET and 99Tcm-MIBI SPETG Schulz, J von Dahl, H J Kaiser, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Surgical Neurology|July 2, 1999
Preoperative PET activation for assessment of motor cortex area in precentral chondromaM Schreckenberger, U Spetzger, O Sabri, et al.
Scientific Reports|May 11, 2026
Efficiency of afamin and fibroblast growth factor 21 for early prediction of gestational diabetes mellitusAbdelrahman O Sabri, Mostafa M Elhady, Eman H A Hemida, et al.
Stroke|March 6, 1999
Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathyO Sabri, E B Ringelstein, D Hellwig, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1997
Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PETU Cremerius, R Bares, J Weis, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 1995
[Comparison of relative 18FDG uptake with metabolic rate (MRGlucose) in the myocardium in CAD, classified by 99m-Tc-MIBI]U Büll, Y Foroutan, D Hellwig, et al.
EJNMMI Research|June 4, 2016
Impact of attenuation correction on clinical [(18)F]FDG brain PET in combined PET/MRIP Werner, M Rullmann, A Bresch, et al.
Nuklearmedizin. Nuclear Medicine|December 6, 2008
[FDG-PET in Hodgkin lymphoma]C Kobe, M Dietlein, C Mauz-Körholz, et al.
European Journal of Neurology|April 29, 2006
Correlation of cognitive status, MRI- and SPECT-imaging in CADASIL patientsR Scheid, C Preul, T Lincke, et al.
Journal of Neurology|April 12, 2006
Profound midbrain atrophy in patients with Wilson's disease and neurological symptoms?K Strecker, J P Schneider, H Barthel, et al.
Nuclear Medicine Communications|December 1, 1996
Imaging of beta-oxidation by static PET with 14(R,S)-[18F]-fluoro-6-thiaheptadecanoic acid (FTHA) in patients with advanced coronary heart disease: a comparison with 18FDG-PET and 99Tcm-MIBI SPETG Schulz, J von Dahl, H J Kaiser, et al.
Pageof 12